Ascorbic acid (vitamin C) synergistically enhances the therapeutic effect of targeted therapy in chronic lymphocytic leukemia.

Walaa DarwicheCathy GomilaHakim Ouled-HaddouMarie NaudotCécile DouallePierre MorelFlorence Nguyen-KhacLoïc GarçonJean-Pierre MarolleauHussein Ghamlouch

Published in: Journal of experimental & clinical cancer research : CR (2020)

These preclinical results point to AA as an adjuvant therapy with potential to further improve CLL treatments in combination with targeted therapies.

Keyphrases

chronic lymphocytic leukemia
cell therapy
risk assessment
climate change